AKEBIA THERAPEUTICS INC revenue for the last year amounted to 176.33 M EUR, the most of which — 176.33 M EUR — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 273.29 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought AKEBIA THERAPEUTICS INC 176.33 M EUR, and the year before that — 273.29 M EUR.